The effects of nicotine, denicotinized tobacco, and nicotine-containing tobacco on cigarette craving, withdrawal, and self-administration in male and female smokers

Behavioural Pharmacology

Volumn 21, Issue 2, 2010, Pages 144-152

  Barrett, Sean P ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINE;

ADULT; ARTICLE; CIGARETTE SMOKING; CLINICAL ARTICLE; DENICOTINIZED TOBACCO; FEMALE; HUMAN; MALE; MOTIVATION; RELAXATION SENSATION; SATISFACTION; SEX DIFFERENCE; SMOKING CESSATION; SYMPTOM; TOBACCO; WITHDRAWAL SYNDROME;

ADULT; BEHAVIOR, ADDICTIVE; BREATH TESTS; CARBON MONOXIDE; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MOTIVATION; NEBULIZERS AND VAPORIZERS; NICOTINE; PATIENT SATISFACTION; SELF ADMINISTRATION; SEX CHARACTERISTICS; SMOKING; SUBSTANCE WITHDRAWAL SYNDROME; TIME FACTORS; TOBACCO; TOBACCO USE DISORDER;

EID: 77949813576     PISSN: 09558810     EISSN: None     Source Type: Journal    
DOI: 10.1097/FBP.0b013e328337be68     Document Type: Article

References (57)

1. Baldinger B, Hasenfratz M, Battig K (1995). Switching to ultralow nicotine cigarettes: effects of different tar yields and blocking of olfactory cues. Pharmacol Biochem Behav 50:233-239.
2. Barrett SP, Tichauer M, Leyton M, Pihl RO (2006). Nicotine increases alcohol self-administration in non-dependent male smokers. Drug Alcohol Depend 81:197-204.
3. Barrett SP, Pihl RO, Benkelfat C, Brunelle C, Young SN, Leyton M (2008). The role of dopamine in alcohol self-administration in humans: individual differences. Eur Neuropsychopharmacol 18:439-447.
4. Becker KM, Rose JE, Albino AP (2008). A randomized trial of nicotine replacement therapy in combination with reduced-nicotine cigarettes for smoking cessation. Nicotine Tob Res 10:1139-1148.
5. Bond AJ, Lader MH (1972). Proceedings: residual effects of a new benzodiazepine: flurazepam. Br J Pharmacol 44:343-344.
6. Brauer LH, Behm FM, Lane JD, Westman EC, Perkins C, Rose JE (2001). Individual differences in smoking reward from de-nicotinized cigarettes. Nicotine Tob Res 3:101-109.
7. Brody AL, Mandelkem MA, Costello MR, Abrams AL, Scheibal D, Farahi J, et al. (2009). Brain nicotine acetylcholine receptor occupancy: effects of smoking a denicotinized cigarette. Int J Neuropsychopharmacol 12:305-316.
8. Brown RA, Lejuez CW, Kahler CW, Strong DR, Zvolensky MJ (2005). Distress tolerance and early smoking lapse. Clin Psychol Rev 25:713-733.
9. Buchhalter AR, Scrinel L, Eissenberg T (2001). Withdrawal suppressing effects of a novel smoking system: comparison with own brand, not own brand and denicotinized cigarettes. Nicotine Tob Res 3:111-118.
10. Butschky MF, Bailey D, Henningfield JE, Pickworth WB (1995). Smoking without nicotine delivery decreases withdrawal in 12-h abstinent smokers. Pharmacol Biochem Behav 50:91-96.
11. Clemens KJ, Caillé S, Stinus L, Cador M (2009). The addition of five minor tobacco alkaloids increases nicotine-induced hyperactivity, sensitization and intravenous self-administration in rats. Int J Neuropsychopharmacol 15:1-12.
12. Cook MR, Gerkovich MM, O'Connell KA, Potocky M (1995). Reversal theory constructs and cigarette availability predict lapse early in smoking cessation. Res Nurs Health 18:217-224.
13. D'Angelo ME, Reid RD, Brown KS, Pipe AL (2001). Gender differences in predictors for long-term smoking cessation following physician advice and nicotine replacement therapy. Can J Public Health 92:418-422.
14. Dar R, Frenk H (2004). Do smokers self-administer pure nicotine? A review of the evidence. Psychopharmacology 173:18-26.
15. Dar R, Frenk H (2007). Reevaluating the nicotine delivery kinetics hypothesis. Psychopharmacology 192:1-7.
16. Donny EC, Jones M (2009). Prolonged exposure to denicotinized cigarettes with or without transdermal nicotine. Drug Alcohol Depend 104:23-33.
17. Donny EC, Houtsmuller E, Stitzer ML (2007). Smoking in the absence of nicotine: behavioural, subjective and physiological effects over 11 days. Addiction 102:324-334.
18. Evans SE, Blank M, Sams C, Weaver MF, Eissenberg T (2006). Transdermal nicotine-induced tobacco abstinence symptom suppression: nicotine dose and smokers' gender. Exp Clin Psychopharmacol 14:121-135.
19. Fagerstrom KO (1999). Interventions for treatment-resistant smokers. Nicotine To b R e s 1 (Suppl 2):201-205.
20. Finnegan JK, Larson PS, Haag HB (1945). The role of nicotine in the cigarette habit. Science 102:94-96.
21. Fowler JS, Volkow ND, Wang GJ, Pappas N, Logan J, MacGregor R, et al. (1996). Inhibition of monoamine oxidase B in the brains of smokers. Nature 379:733-736.
22. Fulton HG, Barrett SP (2008). A demonstration of intervenous nicotine self administration in humans? Neuropsychopharmacol 33:2042-2043.
23. Furberg H, Sullivan PF, Maes H, Prescott CA, Lerman C, Bulik C, Kendler KS (2005). The types of regular cigarette smokers: a latent class analysis. Nicotine Tob Res 7:351-360.
24. Gross J, Lee J, Stitzer ML (1997). Nicotine-containing versus de-nicotinized cigarettes: effects on craving and withdrawal. Pharmacol Biochem Behav 57:159-165.
25. Hoffmann D, Hoffmann I (1998). Tobacco smoke components. Beitr Tab forsch Int 18:49-52.
26. Hughes JR, Gulliver SB, Amori G, Mireault GC, Fenwick JF (1989). Effect of instructions and nicotine on smoking cessation, withdrawal symptoms and self-administration of nicotine gum. Psychopharmacology 99:486-491.
27. Hughes JR, Grass JA, Pillitteri JL (2000). Treatment resistant smokers: a pilot study of nicotine nasal spray and inhaler. J Addict Dis 19:95-100.
28. Hughes JR, Shiffman S, Callas P, Zhang J (2003). A meta-analysis of the efficacy of over-the-counter nicotine replacement. Tob Control 12:21-27.
29. Hughes JR, Keely J, Naud S (2004). Shape of the relapse curve and long-term abstinence among untreated smokers. Addiction 99:29-38.
30. Killen JD, Fortmann SP, Newman B, Varady A (1990). Evaluation of a treatment approach combining nicotine gum with self-guided behavioural treatments for smoking relapse prevention. J Consult Clin Psychol 58:85-92.
31. Nesbitt PD (1973). Smoking, physiological arousal, and emotional response. J Pers Soc Psychol 25:137-144.
32. Perkins KA, Donny E, Caggiula AR (1999). Sex differences in nicotine effects and self-administration: review of human and animal evidence. Nicotine Tob Res 1:301-315.
33. Perkins KA, Gerlach D, Vender J, Grobe J, Meeker J, Hutchinson S (2001). Sex differences in the subjective and reinforcing effects of visual and olfactory cigarette smoke stimuli. Nicotine Tob Res 3:141-150.
34. Perkins KA, Doyle T, Ciccocioppo M, Conklin C, Sayette M, Caggiula A (2006). Sex differences in the influence of nicotine dose instructions on the reinforcing and self-reported rewarding effects of smoking. Psychopharmacology 184:600-607.
35. Perkins KA, Grottenthaler A, Ciccocioppo MM, Conklin CA, Sayette MA, Wilson AS (2009). Mood, nicotine, and dose expectancy effects on acute responses to nicotine spray. Nicotine Tob Res 11:540-546.
36. Piasecki TM, Jorenby DE, Smith SS, Fiore MC, Baker TB (2003). Smoking withdrawal dynamics: III. Correlates of withdrawal heterogeneity. Exp Clin Psychopharmacol 11:276-285.
37. Pickworth WB, Fant RV, Nelson RA, Rohrer MS, Henningfield JE (1999). Pharmacodynamic effects of new de-nicotinized cigarettes. Nicotine Tob Res 1:357-364.
38. Rezaishiraz H, Hyland A, Mahoney MC, O'Connor RJ, Cummings KM (2007). Treating smokers before the quit date: can nicotine patches and denicoti-nized cigarettes reduce cravings? Nicotine Tob Res 9:1139-1146.
39. Rodd-Henricks ZA, Melendez RI, Zaffaroni A, Goldstein A, McBride WJ, Li TK (2002). The reinforcing effects of acetaldehyde in the posterior ventral tegmental area of alcohol-preferring rats. Pharmacol Biochem Behav 72:55-64.
40. Rose JE (2006). Nicotine and nonnicotine factors in cigarette addiction. Psychopharmacology 184:274-285.
41. Rose JE, Zinser MC, Tashkin TP, Newcomb R, Ertle A (1984). Subjective response to cigarette smoking following airway anesthetization. Addict Behav 9:211-215.
42. Rose JE, Tashkin DP, Ertle A, Zinser MC, Lafer R (1985). Sensory blockade of smoking satisfaction. Pharmacol Biochem Behav 23:289-293.
43. Rose JE, Behm FM, Westman EC, Johnson M (2000). Dissociating nicotine and non-nicotine components of cigarette smoking. Pharmacol Biochem Behav 67:71-81.
44. Schneider NG, Olmstead RE, Franzon MA, Lunell E (2001). The nicotine inhaler: clinical pharmacokinetics and comparison with other nicotine treatments. Clin Pharmacokinet 40:661-684.
45. Schneider NG, Olmstead RE, Nides M, Mody FV, Otte-Colquette P, Patel DK (2004). Comparative testing of 5 nicotine systems: initial use and preferences. Am J Health Behav 28:72-86.
46. Schneider NG, Terrace S, Koury MA, Patel DK, Vaghaiwalla B, Pendergrass R, et al. (2005). Comparison of three nicotine treatments: initial reactions and preferences with guided use. Psychopharmacology 182:545-550.
47. Society for Research on Nicotine and Tobacco Subcommittee on Biochemical Verification (2002). Biochemical verification of tobacco use and cessation. Nicotine Tob Res 4:149-159
48. SPSS (2002). Linear mixed effects modeling in SPSS: technical report. Chicago USA. Talhout R, Opperhuizen A, van Amsterdam JG (2007). Role of acetaldehyde in tobacco smoke addiction. Eur Neuropsychopharmacol 17:627-636.
49. Toll BA, Katulak NA, McKee SA (2006). Investigating the factor structure of the Questionnaire on Smoking Urges-Brief (QSU-Brief). Addict Behav 31:1231-1239.
50. US Department of Health and Human Services. Nicotine addiction: a report of the Surgeon General 1988; DHHS publication number CDC 88-8406.
51. Villegier AS, Lotfipour S, McQuown SC, Belluzzi JD, Leslie FM (2007). Tranylcypromine enhancement of nicotine self-administration. Neuropharmacology 52:1415-1425.
52. Westman EC, Behm FM, Rose JE (1996). Dissociating the nicotine and airway sensory effects of smoking. Pharmacol Biochem Behav 53:309-315.
53. Wetter DW, Kenford SL, Smith SS, Fiore MC, Jorenby DE, Baker TB (1999). Gender differences in smoking cessation. J Consult Clin Psychol 67:555-562.
54. Willner P, Jones C (1996). Effects of mood manipulation on subjective and behavioural measures of cigarette craving. Behav Pharmacol 6:1-9.
55. Willner P, Hardman S, Eaton G (1995). Subjective and behavioural evaluation of cigarette cravings. Psychopharmacology 118:171-177.
56. World Health Organization (2008). Report on the Global Tobacco Epidemic, 2008. Geneva Switzerland.
57. Yudkin PL, Jones L, Lancaster T, Fowler GH (1996). Which smokers are helped to give up smoking using transdermal nicotine patches? Results from a randomized, double-blind, placebo-controlled trial. Br J Gen Pract 46:145-148.